花旗:比亞迪增發計劃短期料損股價,長期有助增強競爭力
彭博新聞社報道,比亞迪向中國證監會提交增發H股的申請。花旗稱,增發或稀釋其每股收益,股價初期反應料負面,但實際影響料有限。更長期看,增發有助於增強公司在電動車、電池和軟件等領域的先發優勢。
分析師Jeff Chung在報告中表示,公司擬增發不超過H股總股本20%的股份,這將佔其A+H股總股本的6.7%,增發對其每股收益的稀釋影響預計在低中個位數。
維持買進評級,股價催化劑包括:預計比亞迪漢11月份的出貨 量約1萬輛,12月份產量料進一步升至1.1-1.25萬輛。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.